Home

Duft so Behinderung achim aigner leipzig Präsentation Beschleunigung Labor

Mitarbeiter des Rudolf-Boehm-Institutes
Mitarbeiter des Rudolf-Boehm-Institutes

Focused Ultrasound Therapy
Focused Ultrasound Therapy

Cell-type specific and non-redundant anti-proliferative effects of  shRNA-mediated Galpha12- and Galpha13 knockdown in lung canc
Cell-type specific and non-redundant anti-proliferative effects of shRNA-mediated Galpha12- and Galpha13 knockdown in lung canc

Silencing of Neuropilins and GIPC1 in pancreatic ductal adenocarcinoma  exerts multiple cellular and molecular antitumor effects | Scientific  Reports
Silencing of Neuropilins and GIPC1 in pancreatic ductal adenocarcinoma exerts multiple cellular and molecular antitumor effects | Scientific Reports

Vorlage Geschäftsbrief mit Siegel
Vorlage Geschäftsbrief mit Siegel

Drug Delivery by Ultrasound-Responsive Nanocarriers for Cancer Treatment
Drug Delivery by Ultrasound-Responsive Nanocarriers for Cancer Treatment

Multiple effects of the special ATâ•'rich binding protein 1 (SATB1) in  colon carcinoma
Multiple effects of the special ATâ•'rich binding protein 1 (SATB1) in colon carcinoma

C:/Users/julia/biotechnologische Studenteninitiative (btS) e.V/Leipzig -  ScieGuide 2019/ScieGuide final 08.08/ScieGuide070819.sl
C:/Users/julia/biotechnologische Studenteninitiative (btS) e.V/Leipzig - ScieGuide 2019/ScieGuide final 08.08/ScieGuide070819.sl

Front Cover: Balancing Histone Deacetylase (HDAC) Inhibition and  Drug‐likeness: Biological and Physicochemical Evaluation of Class I  Selective HDAC Inhibitors (ChemMedChem 9/2022) - Schäker‐Hübner - 2022 -  ChemMedChem - Wiley Online Library
Front Cover: Balancing Histone Deacetylase (HDAC) Inhibition and Drug‐likeness: Biological and Physicochemical Evaluation of Class I Selective HDAC Inhibitors (ChemMedChem 9/2022) - Schäker‐Hübner - 2022 - ChemMedChem - Wiley Online Library

Analysis of SATB1 in Head and Neck Squamous Cell Carcinoma
Analysis of SATB1 in Head and Neck Squamous Cell Carcinoma

Loop | Achim Aigner
Loop | Achim Aigner

Accommodation – CAS in Radiopharmaceutical Chemistry/Radiopharmacy | ETH  Zurich
Accommodation – CAS in Radiopharmaceutical Chemistry/Radiopharmacy | ETH Zurich

Tau Silencing by siRNA in the P301S Mouse Model of Tauopathy
Tau Silencing by siRNA in the P301S Mouse Model of Tauopathy

Impact of medication on blood transcriptome reveals off-target regulations  of beta-blockers | PLOS ONE
Impact of medication on blood transcriptome reveals off-target regulations of beta-blockers | PLOS ONE

Programme – CAS in Radiopharmaceutical Chemistry/Radiopharmacy | ETH Zurich
Programme – CAS in Radiopharmaceutical Chemistry/Radiopharmacy | ETH Zurich

فلسفي دافئ تحويلات بند تشابه لفة aigner et al 2011 - afsassociation.org
فلسفي دافئ تحويلات بند تشابه لفة aigner et al 2011 - afsassociation.org

Nanoparticle-complexed antimiRs for inhibiting tumor growth and metastasis  in prostate carcinoma and melanoma
Nanoparticle-complexed antimiRs for inhibiting tumor growth and metastasis in prostate carcinoma and melanoma

Exploring the MIR143-UPAR Axis for the Inhibition of Human Prostate Cancer  Cells In Vitro and In Vivo: Molecular Therapy - Nucleic Acids
Exploring the MIR143-UPAR Axis for the Inhibition of Human Prostate Cancer Cells In Vitro and In Vivo: Molecular Therapy - Nucleic Acids

Achim Aigner | Leipzig University, Germany | Pharmaceutica 2017 |  Conferenceseries
Achim Aigner | Leipzig University, Germany | Pharmaceutica 2017 | Conferenceseries

Analysis of Transcriptional Regulation of the Human miR-17-92 Cluster;  Evidence for Involvement of Pim-1
Analysis of Transcriptional Regulation of the Human miR-17-92 Cluster; Evidence for Involvement of Pim-1

Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology,  Pharmacy and Toxicology
Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology, Pharmacy and Toxicology

Mitarbeiter des Rudolf-Boehm-Institutes
Mitarbeiter des Rudolf-Boehm-Institutes

Leipziger Pharmakologen forschen an Molekülen gegen Prostatakrebs
Leipziger Pharmakologen forschen an Molekülen gegen Prostatakrebs

European Technology Platform on Nanomedicine
European Technology Platform on Nanomedicine

Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology,  Pharmacy and Toxicology
Achim AIGNER | University of Leipzig, Leipzig | Institute of Pharmacology, Pharmacy and Toxicology